Amneal Pharmaceuticals, Inc.
AMRX
$11.95
-$0.17-1.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 212.85% | 1,618.59% | 273.99% | 113.31% | 68.49% |
| Total Depreciation and Amortization | -25.56% | -8.29% | 8.17% | 8.34% | 16.15% |
| Total Amortization of Deferred Charges | -45.50% | -37.34% | -7.71% | 0.12% | 46.16% |
| Total Other Non-Cash Items | 0.42% | 234.80% | 7.91% | -6.11% | -54.39% |
| Change in Net Operating Assets | -156.23% | -218.64% | 38.10% | -788.42% | -59.30% |
| Cash from Operations | 10.36% | -16.45% | 111.36% | 267.98% | -13.06% |
| Capital Expenditure | -92.17% | 12.05% | -147.59% | -40.38% | -90.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -400.00% | -105.94% | -20.00% | 56.70% | 96.98% |
| Cash from Investing | -183.04% | -8.46% | -310.63% | 9.93% | 49.33% |
| Total Debt Issued | -- | -- | -- | 354.17% | -100.00% |
| Total Debt Repaid | 88.97% | -2,828.92% | 42.41% | -271.63% | 78.85% |
| Issuance of Common Stock | 266.23% | 5.83% | 91.34% | 146.43% | 251.16% |
| Repurchase of Common Stock | 17.05% | 33.51% | -18.87% | -200.04% | -148.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.55% | -1,466.74% | -221.33% | 88.55% | 96.70% |
| Cash from Financing | 83.47% | 164.37% | -18.81% | -69.15% | 39.30% |
| Foreign Exchange rate Adjustments | 71.76% | -10,014.29% | -203.96% | -184.85% | -468.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.98% | 438.71% | 865.81% | -5.34% | 1,045.00% |